Table 1.
Overall (n = 56) | |
---|---|
Male | 28 (50.0) |
Female | 28 (50.0) |
Median age at diagnosis (IQR) [years] | 68 (9.5) |
Comorbidities | |
Chronic pancreatitis | 9 (16.1) |
Diabetes | 8 (14.3) |
Detection | |
Incidental finding | 44 (78.6) |
Abdominal pain | 7 (12.5) |
Pancreatitis | 5 (8.9) |
Mode of detection | |
CT | 46 (82.2) |
MRI | 7 (12.5) |
US | 3 (5.4) |
BD-IPMN | 41 (73.2) |
MD-IPMN | 9 (16.1) |
MT-IPMN | 6 (10.7) |
Localization of IPMN1 | |
Head | 22 (39.3) |
Body | 15 (26.8) |
Uncinated process | 14 (25.0) |
Tail | 9 (16.1) |
Neck | 8 (12.3) |
Median cyst size at diagnosis (IQR) [mm] | 16.0 (13) |
MPD-size 3.5–5 mm | 10 (17.9) |
WF at diagnosis (WF +) 2 | 15 (26.8) |
Cyst size ≥ 3 cm | 9 |
Thickened or enhancing cyst walls | 2 |
MPD-size 5–9 mm | 8 |
Recurrent pancreatitis | 2 |
HRS at diagnosis (HRS +)2 | 3 (5.6) |
Obstructive jaundice | 1 |
High-grade dysplasia on EUS-FNA | 2 |
Values are n (%) unless otherwise noted. BD branch duct, MD main duct, MT mixed type, WF worrisome feature, MPD main pancreatic duct, IQR interquartile range
1Multiple localizations possible
2Presence of at least one worrisome feature or one high-risk stigmata at diagnosis. Multiple possible